13D Filing: Aisling Capital III LP and Agile Therapeutics Inc (AGRX)

Page 11 of 11

Page 11 of 11 – SEC Filing

CUSIP No. 00847L100
SCHEDULE 13D
Page 11 of 11
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 1, 2018
AISLING CAPITAL III, LP
By:
Aisling Capital Partners III, LP
General Partner
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III, LP
By:
Aisling Capital Partners III LLC
General Partner
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
AISLING CAPITAL PARTNERS III LLC
By:
/s/ Dennis Purcell
Name: Dennis Purcell
Title: Managing Member
/s/ Steven Elms
Steven Elms
/s/ Dennis Purcell
Dennis Purcell
/s/ Andrew Schiff
Andrew Schiff

Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

Follow Agile Therapeutics Inc (NASDAQ:AGRX)

Page 11 of 11